1. Home
  2. ARDX vs MGIC Comparison

ARDX vs MGIC Comparison

Compare ARDX & MGIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARDX
  • MGIC
  • Stock Information
  • Founded
  • ARDX 2007
  • MGIC 1983
  • Country
  • ARDX United States
  • MGIC Israel
  • Employees
  • ARDX N/A
  • MGIC N/A
  • Industry
  • ARDX Biotechnology: Pharmaceutical Preparations
  • MGIC Computer Software: Prepackaged Software
  • Sector
  • ARDX Health Care
  • MGIC Technology
  • Exchange
  • ARDX Nasdaq
  • MGIC Nasdaq
  • Market Cap
  • ARDX 882.9M
  • MGIC 788.0M
  • IPO Year
  • ARDX 2014
  • MGIC 1991
  • Fundamental
  • Price
  • ARDX $6.52
  • MGIC $19.64
  • Analyst Decision
  • ARDX Strong Buy
  • MGIC Buy
  • Analyst Count
  • ARDX 9
  • MGIC 2
  • Target Price
  • ARDX $10.50
  • MGIC $18.00
  • AVG Volume (30 Days)
  • ARDX 3.5M
  • MGIC 44.1K
  • Earning Date
  • ARDX 10-30-2025
  • MGIC 08-13-2025
  • Dividend Yield
  • ARDX N/A
  • MGIC 2.90%
  • EPS Growth
  • ARDX N/A
  • MGIC 16.93
  • EPS
  • ARDX N/A
  • MGIC 0.78
  • Revenue
  • ARDX $386,146,000.00
  • MGIC $584,528,000.00
  • Revenue This Year
  • ARDX $16.83
  • MGIC $11.11
  • Revenue Next Year
  • ARDX $28.55
  • MGIC $6.83
  • P/E Ratio
  • ARDX N/A
  • MGIC $24.99
  • Revenue Growth
  • ARDX 83.88
  • MGIC 11.98
  • 52 Week Low
  • ARDX $3.21
  • MGIC $10.24
  • 52 Week High
  • ARDX $7.18
  • MGIC $22.00
  • Technical
  • Relative Strength Index (RSI)
  • ARDX 79.80
  • MGIC 45.20
  • Support Level
  • ARDX $6.38
  • MGIC $19.10
  • Resistance Level
  • ARDX $6.65
  • MGIC $20.85
  • Average True Range (ATR)
  • ARDX 0.22
  • MGIC 0.52
  • MACD
  • ARDX 0.00
  • MGIC -0.09
  • Stochastic Oscillator
  • ARDX 85.53
  • MGIC 42.01

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About MGIC Magic Software Enterprises Ltd.

Magic Software Enterprises Ltd is a software development company. The company's operating segment includes Software Services and IT Professional Services. The company generates maximum revenue from the IT Professional Services segment. IT Professional Services segment offers IT services in the areas of infrastructure design and delivery, application development, technology planning and implementation services, communications services and solutions, as well as supplemental outsourcing services. Geographically, it derives a majority of revenue from the United States and also has a presence in Israel, Europe, Japan, and Other countries.

Share on Social Networks: